Colchicine to prevent first heart problems in at-risk adults
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether taking a daily low dose of colchicine, a medicine used for inflammation, can help prevent a first heart attack or other heart problems in people who are at higher risk due to their risk factors. If you qualify, you would be assigned to take either colchicine or a placebo (a pill with no active medicine) to see if it helps keep your heart healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 70 years old.
- You need to have at least three risk factors for heart disease, such as high blood pressure, high cholesterol, diabetes, smoking, or a family history.
- You must not already have been diagnosed with coronary artery disease.
- Your kidneys must be working well (checked by a lab test).
- You cannot have a history of stroke, heart failure, or other serious heart conditions.
- You cannot currently be taking colchicine or be allergic to it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests whether a daily low-dose of colchicine, a common anti-inflammatory medicine, can help prevent heart attacks and strokes in people with type 2 diabetes who do not yet have heart disease. If it works, it could be a simple addition to your current diabetes care.
This study tests whether a daily low dose of colchicine, a medicine used for gout and inflammation, can reduce inflammation and improve blood vessel and bone health in people with chronic kidney disease. It might help prevent complications like heart disease and weak bones.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.